Subscribe
Intravitreal gene therapy continues to be well tolerated and shows robust efficacy
Intravitreally injected hRPCs improve vision in retinitis pigmentosa cases
Stem cells for dry AMD with GA show promise in early study
Exploring novel gene therapy approaches to treat ocular disease
Mark R. Barakat, MD, FASRS; David Eichenbaum, MD, FASRS
Dilsher Dhoot, MD, FASRS; Jordana G. Fein, MD, MS; Deep Parikh, MD; Xiao-Yi (Ellie) Zhou, MD
Dante Pieramici, MD, FASRS; Dean Eliott, MD; Robin A. Vora, MD; Charles C. Wykoff, MD, PhD, FASRS
David Almeida, MD, PhD, MBA; Margaret A. Chang, MD, MS; Arshad M. Khanani, MD, MA, FASRS; Jessica Randolph, MD
Ramiro Maldonado, MD; Rebecca Nelson, MS, CGC; Robert A. Sisk, MD, FACS, FASRS
Judy E. Kim, MD, FARVO, FASRS; Anat Loewenstein, MD, MHA; Deepak Sambhara, MD, FASRS
September 26, 2026
SriniVas R. Sadda, MD, FARVO; Mark R. Barakat, MD, FASRS; David A. Eichenbaum, MD, FASRS
Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO
Basil Williams, MD; Maura Di Nicola, MD
Deep Parikh, MD
Dilsher S. Dhoot, MD, FASRS
Uday Devgan, MD, FACS, FRCS
Mile Brujic, OD, FAAO; Pierce Kenworthy, OD, FAAO; Blair Lonsberry, MS, OD, MEd, FAAO
Carl J. Danzig, MD, FASRS
Damon Dierker, OD FAAO; Maria Pribis, OD